{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:21:06Z","timestamp":1793888466528,"version":"4.8.0"},"reference-count":59,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["PR00P3_201621"],"award-info":[{"award-number":["PR00P3_201621"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013850","name":"Helmut Horten Foundation","doi-asserted-by":"crossref","award":["2023-YIG-098"],"award-info":[{"award-number":["2023-YIG-098"]}],"id":[{"id":"10.13039\/501100013850","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2016-02363491"],"award-info":[{"award-number":["2016-02363491"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["Fellowships for Abroad Post-Doc 2023"],"award-info":[{"award-number":["Fellowships for Abroad Post-Doc 2023"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EHA","award":["Research Mobility Grant"],"award-info":[{"award-number":["Research Mobility Grant"]}]},{"name":"AIRC\/Cancer Research UK (CRUK)\/AECC","award":["22791"],"award-info":[{"award-number":["22791"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,9,22]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chimeric antigen receptor (CAR) T cells targeting CD19 induce durable responses in B-cell acute lymphoblastic leukemia (B-ALL). However, the contribution of the tumor microenvironment to the therapeutic response after CAR T-cell treatment remains incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed single-cell RNA sequencing and spectral flow cytometry-based analyses of bone marrow-resident immune cells from B-ALL patients before and after CAR T-cell treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed profound changes in the microenvironment in response to CAR T-cell-mediated inflammation, including an increase in myeloid cells. Significant induction of the interferon response, hypoxia, and TGF-\u03b2 signaling was accompanied by expansion of myeloid-derived suppressor cells (MDSCs) and endogenous exhausted CD8+ T cells. PD-1 expression in endogenous T cells post-treatment was associated with a lack of durable response in the cohort of patients analyzed. Further, we revealed that HIF-1\u03b1, VEGF, and TGFBR2 are key players in the intercellular communication between CAR T cells and the immune niche, potentially driving widespread T-cell dysfunction. Infusion of anti-CD19 CAR T cells led to increased accumulation of human MDSCs, exacerbation of a hypoxic environment and T-cell exhaustion in hematopoietic stem\/progenitor cell-humanized mice bearing a human tumor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In conclusion, CAR T-cell-mediated myeloid activation is associated with pathways of immune dysregulation that may antagonize the effects of therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-011768","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:15:14Z","timestamp":1761286514000},"page":"e011768","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct03389035","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05252403","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03389035","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Marianna","family":"Ponzo","sequence":"first","affiliation":[{"name":"Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"},{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Drufuca","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy"},{"name":"IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Buracchi","sequence":"additional","affiliation":[{"name":"Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco M","family":"Sindoni","sequence":"additional","affiliation":[{"name":"Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"},{"name":"School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Nucera","sequence":"additional","affiliation":[{"name":"Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bugarin","sequence":"additional","affiliation":[{"name":"Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Bason","sequence":"additional","affiliation":[{"name":"IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazisa","family":"Rossetti","sequence":"additional","affiliation":[{"name":"IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Bonnal","sequence":"additional","affiliation":[{"name":"IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Meli","sequence":"additional","affiliation":[{"name":"Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Rambaldi","sequence":"additional","affiliation":[{"name":"Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Lussana","sequence":"additional","affiliation":[{"name":"Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Moretti","sequence":"additional","affiliation":[{"name":"Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"},{"name":"School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Dastoli","sequence":"additional","affiliation":[{"name":"Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Risca","sequence":"additional","affiliation":[{"name":"Bicocca Bioinformatics, Biostatistics and Bioimaging B4 Centre, Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7898-9988","authenticated-orcid":false,"given":"Christian","family":"Pellegrino","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus G","family":"Manz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Galimberti","sequence":"additional","affiliation":[{"name":"Bicocca Bioinformatics, Biostatistics and Bioimaging B4 Centre, Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy"},{"name":"Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[{"name":"Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gaipa","sequence":"additional","affiliation":[{"name":"Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[{"name":"Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Pagani","sequence":"additional","affiliation":[{"name":"IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy"},{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2474-2159","authenticated-orcid":false,"given":"Chiara F","family":"Magnani","sequence":"additional","affiliation":[{"name":"Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy"},{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"2025111301352935000_13.10.e011768.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"2025111301352935000_13.10.e011768.2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007118","article-title":"Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3","volume":"11","author":"Shah","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2025111301352935000_13.10.e011768.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2406526"},{"key":"2025111301352935000_13.10.e011768.4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867013","article-title":"The Past, Present, and Future of Non-Viral CAR T Cells","volume":"13","author":"Moretti","year":"2022","journal-title":"Front Immunol"},{"key":"2025111301352935000_13.10.e011768.5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOH.0000000000000178","article-title":"Donor-derived CD19-targeted T cells in allogeneic transplants","volume":"22","author":"Magnani","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"2025111301352935000_13.10.e011768.6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138473"},{"key":"2025111301352935000_13.10.e011768.7","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-025-01260-6","article-title":"Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation","volume":"15","author":"Lussana","year":"2025","journal-title":"Blood Cancer J"},{"key":"2025111301352935000_13.10.e011768.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00642"},{"key":"2025111301352935000_13.10.e011768.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.008"},{"key":"2025111301352935000_13.10.e011768.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0360-1"},{"key":"2025111301352935000_13.10.e011768.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16152-z","article-title":"B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12","volume":"12","author":"Hunter","year":"2022","journal-title":"Sci Rep"},{"key":"2025111301352935000_13.10.e011768.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"2025111301352935000_13.10.e011768.13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.omto.2023.07.003","article-title":"Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells","volume":"30","author":"Magnani","year":"2023","journal-title":"Molecular Therapy - Oncolytics"},{"key":"2025111301352935000_13.10.e011768.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0036-4"},{"key":"2025111301352935000_13.10.e011768.15","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.207"},{"key":"2025111301352935000_13.10.e011768.16","first-page":"3","article-title":"Maximally selected rank statistics in R","volume":"2","author":"Hothorn TaL","year":"2002","journal-title":"R News"},{"key":"2025111301352935000_13.10.e011768.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-090340"},{"key":"2025111301352935000_13.10.e011768.18","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/blood.2024024381","article-title":"Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma","volume":"144","author":"Maurer","year":"2024","journal-title":"Blood"},{"key":"2025111301352935000_13.10.e011768.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.04.015"},{"key":"2025111301352935000_13.10.e011768.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-324004"},{"key":"2025111301352935000_13.10.e011768.21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2025111301352935000_13.10.e011768.22","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0316"},{"key":"2025111301352935000_13.10.e011768.23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165845","article-title":"Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad","volume":"21","author":"Bleve","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025111301352935000_13.10.e011768.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.06.024"},{"key":"2025111301352935000_13.10.e011768.25","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1373231","article-title":"Toll-like receptor 2 ligand and interferon-\u03b3 suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells","volume":"7","author":"Shime","year":"2017","journal-title":"Oncoimmunology"},{"key":"2025111301352935000_13.10.e011768.26","doi-asserted-by":"crossref","unstructured":"Alshetaiwi H , Pervolarakis N , McIntyre LL , et al . Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics. Sci Immunol 2020;5.","DOI":"10.1126\/sciimmunol.aay6017"},{"key":"2025111301352935000_13.10.e011768.27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181952"},{"key":"2025111301352935000_13.10.e011768.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0535-3"},{"key":"2025111301352935000_13.10.e011768.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.008"},{"key":"2025111301352935000_13.10.e011768.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.12.012"},{"key":"2025111301352935000_13.10.e011768.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.007"},{"key":"2025111301352935000_13.10.e011768.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.12.021"},{"key":"2025111301352935000_13.10.e011768.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.09.013"},{"key":"2025111301352935000_13.10.e011768.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0667-5"},{"key":"2025111301352935000_13.10.e011768.35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","article-title":"NR4A transcription factors limit CAR T cell function in solid tumours","volume":"567","author":"Chen","year":"2019","journal-title":"Nature New Biol"},{"key":"2025111301352935000_13.10.e011768.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01152-y"},{"key":"2025111301352935000_13.10.e011768.37","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30937-9"},{"key":"2025111301352935000_13.10.e011768.38","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-0463"},{"key":"2025111301352935000_13.10.e011768.39","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1661"},{"key":"2025111301352935000_13.10.e011768.40","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0036"},{"key":"2025111301352935000_13.10.e011768.41","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1586"},{"key":"2025111301352935000_13.10.e011768.42","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adj9730","article-title":"Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity","volume":"9","author":"Qin","year":"2024","journal-title":"Sci Immunol"},{"key":"2025111301352935000_13.10.e011768.43","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007445"},{"key":"2025111301352935000_13.10.e011768.44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature New Biol"},{"key":"2025111301352935000_13.10.e011768.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.06.036"},{"key":"2025111301352935000_13.10.e011768.46","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002303","article-title":"Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma","volume":"9","author":"Brammer","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2025111301352935000_13.10.e011768.47","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-22-0018"},{"key":"2025111301352935000_13.10.e011768.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01916-x"},{"key":"2025111301352935000_13.10.e011768.49","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd4344","article-title":"A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity","volume":"6","author":"Boulch","year":"2021","journal-title":"Sci Immunol"},{"key":"2025111301352935000_13.10.e011768.50","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221988","article-title":"Self-regulating CAR-T cells modulate cytokine release syndrome in adoptive T-cell therapy","volume":"221","author":"Lin","year":"2024","journal-title":"J Exp Med"},{"key":"2025111301352935000_13.10.e011768.51","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1786","article-title":"Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling","volume":"372","author":"Weber","year":"2021","journal-title":"Science"},{"key":"2025111301352935000_13.10.e011768.52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010162","article-title":"Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity","volume":"6","author":"Adusumilli","year":"2014","journal-title":"Sci Transl Med"},{"key":"2025111301352935000_13.10.e011768.53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100587"},{"key":"2025111301352935000_13.10.e011768.54","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0333-1"},{"key":"2025111301352935000_13.10.e011768.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.10.003"},{"key":"2025111301352935000_13.10.e011768.56","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02754-1"},{"key":"2025111301352935000_13.10.e011768.57","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.ymthe.2020.06.025","article-title":"Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy","volume":"28","author":"Innamarato","year":"2020","journal-title":"Mol Ther"},{"key":"2025111301352935000_13.10.e011768.58","unstructured":"Ponzo M , Drufuca L , Buracchi C , et al . Single cell RNA-seq analysis of bone marrow (BM) samples of patients with B-cell acute lymphoblastic leukemia treated with anti-CD19 CAR T cells. BioStudies 2025."},{"key":"2025111301352935000_13.10.e011768.59","unstructured":"Witkowski MT , Dolgalev I , Tsirigos A , et al . The Evolving Immune Microenvironment of B-cell Acute Lymphoblastic Leukemia. Gene Expression Omnibus 2020."}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-011768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:36:13Z","timestamp":1763026573000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-011768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,23]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/jitc-2025-011768"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-011768","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}